The extremely high cancer selectivity that can be achieved by targeting sulfated GAGs with NT4 [16, 17] confirms the already reported overexpression of these membrane receptors in cancer cells [18, 19, 22–25], which renders them potential tumor markers and cancer selective targets and suggests that NT4 peptides may indeed be selective targeting agents for many different cancers. This evidence concerns the gene NTF4 and neoplasm.